A detailed history of Rock Springs Capital Management LP transactions in Compugen LTD stock. As of the latest transaction made, Rock Springs Capital Management LP holds 989,990 shares of CGEN stock, worth $1.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
989,990
Previous 989,990 -0.0%
Holding current value
$1.4 Million
Previous $1.66 Million 7.7%
% of portfolio
0.06%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.68 - $2.52 $504,000 - $756,000
-300,000 Reduced 23.26%
989,990 $1.66 Million
Q4 2021

Feb 14, 2022

BUY
$4.09 - $7.16 $25,358 - $44,392
6,200 Added 0.48%
1,289,990 $5.55 Million
Q3 2021

Nov 15, 2021

BUY
$5.8 - $8.02 $271,451 - $375,352
46,802 Added 3.78%
1,283,790 $7.66 Million
Q2 2021

Aug 16, 2021

BUY
$6.87 - $9.16 $120,225 - $160,300
17,500 Added 1.44%
1,236,988 $10.2 Million
Q1 2021

May 17, 2021

BUY
$7.67 - $13.77 $658,760 - $1.18 Million
85,888 Added 7.58%
1,219,488 $10.5 Million
Q4 2020

Feb 16, 2021

BUY
$12.07 - $17.95 $9,957 - $14,808
825 Added 0.07%
1,133,600 $13.7 Million
Q3 2020

Nov 16, 2020

BUY
$14.16 - $19.45 $33,984 - $46,680
2,400 Added 0.21%
1,132,775 $18.4 Million
Q2 2020

Aug 14, 2020

BUY
$6.97 - $17.12 $211,713 - $520,020
30,375 Added 2.76%
1,130,375 $17 Million
Q4 2018

Feb 14, 2019

BUY
$2.17 - $3.8 $47,381 - $82,973
21,835 Added 2.03%
1,100,000 $2.39 Million
Q2 2018

Aug 14, 2018

BUY
$3.15 - $4.7 $797,469 - $1.19 Million
253,165 Added 30.69%
1,078,165 $3.56 Million
Q3 2017

Nov 14, 2017

BUY
$2.75 - $3.95 $2.27 Million - $3.26 Million
825,000
825,000 $3.14 Million

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $122M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.